Therefore, the present study aimed to study SMA disease (type I and II) in pediatric patients in Egypt at the molecular level, and elucidate the possibility of using the molecular assessment of NAIP and SMN genes as a useful tool in predicting the severity of SMA among patients. This evidence concerns the gene NAIP and proximal spinal muscular atrophy.